High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

Despite the increasing evidence of the benefit of corticosteroids for the treatment of moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available about the potential role of high doses of steroids for these patients. We evaluated the mortality, the risk of need for mechanica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Clin Microbiol Infect Dis
Autors principals: Monreal, Enric, Sainz de la Maza, Susana, Natera-Villalba, Elena, Beltrán-Corbellini, Álvaro, Rodríguez-Jorge, Fernando, Fernández-Velasco, Jose Ignacio, Walo-Delgado, Paulette, Muriel, Alfonso, Zamora, Javier, Alonso-Canovas, Araceli, Fortún, Jesús, Manzano, Luis, Montero-Errasquín, Beatriz, Costa-Frossard, Lucienne, Masjuan, Jaime, Villar, Luisa María
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7575217/
https://ncbi.nlm.nih.gov/pubmed/33083917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-020-04078-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars